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Abstract
Background: Catharanthus roseus is an important Ayurvedic medication in traditional medicine. It is potentially
used in countries like India, South Africa, China and Malaysia for the healing of diabetes mellitus. Although, the
molecular mechanisms behind this effect are yet to be exclusively explored. Due to the great antidiabetic and
hyperlipidemic potential of c. roseus, we hypothesized that the insulin mimetic effect of ethanolic extract of c.
roseus might add to glucose uptake through improvement in the expression of genes of the glucose transporter
(GLUT) family messenger RNA (mRNA) in liver.
Methods: STZ-induced diabetic rats treated by ethanolic extract of c. roseus 100 mg/kg and 200 mg/kg; and one
group treated with Metformin (100 mg/kg). After final administration of treatment of 4 weeks, blood samples were
collected under fasting conditions, and the body weights (BWs) were measured. Total RNA from liver was extracted
with the Qiagen RNEasy Micro kit (GERMANY) as described in the manufacturer’s instructions. First-strand
complementary DNA (cDNA) was synthesized at 40 °C by priming with oligo-dT12–18 (Invitrogen, USA) and using
Super ScriptII reverse transcriptase according to the protocol provided by the manufacturer (Invitrogen, USA). Real-time
polymerase chain reaction (PCR) amplifications for GLUT-4 (gene ID: 25139) were conducted using Light-Cycler 480
(Roche, USA) with the SyBr® I nucleic acid stain (Invitrogen, USA) according to the manufacturer's instructions.
Polymerase chain reaction products of β-actin primer gene were used as an internal standard.
Results: The proposed study was framed to look at the antidiabetic efficacy of ethanolic extract of c. roseus and an
expression of GLUT-2 and GLUT-4 gene in streptozotocin induced diabetic wistar rats. The doses were administered
orally at a rate of 100 and 200 mg/kg and detrain the glucose transport system in liver for 4 weeks. The observed
results showed a good positive correlation between intracellular calcium and insulin release levels in isolated islets of
Langerhans. The supplementation of ethanolic extract of c. roseus significantly amplified the expression of GLUT gene
mRNA by Real Time PCR in liver of diabetic rats.
Conclusions: We conclude that the observed antidiabetic effect of c. roseus on STZ induced diabetes was a result of
complex mechanisms of GLUT gene mRNA expression. The findings are very encouraging and greatly advocate its
candidature for the design of a novel herbal drug to cure deadly diabetes.
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Background
Diabetes is evolving as one of the most fatal diseases
confronting humanity right behind cancer and cardio-
vascular diseases. Existing databases indicate its high
prevalence, morbidity and mortality rate [1, 2]. About
4 % population worldwide is dying by this deadly disease
and this toll is likely to swell by 5.4 % in the year 2025
[3] additionally diabetes is known to be risk factor for
other diseases as well. India with its rising economy and
rapidly urbanizing population is at a greater risk of this
disease. The number of adults fighting with diabetes in
India is projected to amplify threefold, from the existing
19.4 million in 1995 to 57.2 million in 2025. The world
Health Organigation (WHO) estimated that worldwide,
346 million people have diabetes with more than 80 % of
diabetics living in low and middle-income countries.
The number is expected to grow to double by 2030 [4].
Recent studies on geographical and ethical influences
have revealed that people of Indian origin are highly
prone to diabetes. Diabetes is characterized by hypergly-
cemia due to an absolute or relatively deficient insulin
levels [5]. Although insulin therapy is widely used for
management of diabetes mellitus, its many side effects
such as, insulin resistance, anorexia nervosa, brain atro-
phy, and fatty liver after chronic treatment makes it a
risky proposition [6, 7]. Therefore, extensive research,
which is still at a nascent stage, is required to find more
effective and safer hypoglycemic agents. Medicinal plants
are a rich source of anti-diabetic compounds and have
been used for the treatment of diabetes in the form of
compound drugs. Many of these plant-derived drugs
against diabetes mellitus have received positive approval
from WHO.
Type 2 diabetes mellitus, the most common endocrine
disorder, potentially affects up to 5 % of the western popu-
lation [8–10]. Patients with type 2 diabetes generally suffer
both from reduced insulin secretion and from resistance
to the actions of insulin. Hyperglycemic-hyperinsulinemic
clamp analysis of human type 2 diabetic patients has re-
vealed that insulin resistance in muscle is a direct conse-
quence of the defect in glucose transport [11–13]. The
principal insulin-sensitive glucose transporter in the liver
and muscle is insulin-sensitive glucose transport gene
(GLUT-2 and GLUT-4), which is recruited to the sarco-
lemma following insulin stimulation. The glucose trans-
porter is the primary isoform in the liver and skeletal
muscle and is known to translocate to the cell surface in
response to insulin levels [14, 15] and muscle contraction
[16–18]. Several studies have demonstrated that the glu-
cose transport response to insulin in liver and skeletal
muscle is greatly integrated to/influenced by glucose
transport gene [19, 20].
Catharanthus roseus (L.) G. Don (Apocynaceae) is an
ornamental shrub, belongs to the family Apocynaceae, is
an erected procumbent herb or under shrub containing
latex. that grows up to 30–100 cm in height. It was pre-
viously known as Vinca rosea (L.). it is widely distributed
around the World due to its high survivability in a var-
iety of habitats and use as an ornamental plant [21]. C.
roseus is used traditionally medicine for the treatment of
diabetes in several countries of the world [22] including
like Nigeria [23], India [23, 24] South Africa, China,
Mexico [25] and Malaysia [26]. Roots and leaves of this
plant contain more than 100 alkaloids. It has economic
importance from its alkaloids. The two leaf alkaloids
which are most important in medicine are vinblastine
and vincristine [27]. Among few approaches, high per-
formance liquid chromatography (HPLC) technique is
still widely used for the separation and analysis of sec-
ondary metabolites such as those from C. roseus [28].
Fresh leaf juice of c. roseus has been reported to reduce
blood glucose in diabetic rabbits [24]. Leaf and other part
of c. roseus also widely used as an infusion for the treat-
ment of diabetes [22] and it has gained acceptance from
the pharmaceutical industries [29, 30]. Significant antihy-
perglycemic activities of the alcoholic extract, [31, 32]
aqueous extract, [33] and the dichloromethane-methanol
extract of c. roseus [34] have been reported in laboratory
animals. Although, earlier reports have indicated blood
glucose lowering activity in extracts and leaf powder in
the management of hyperglycemia have not been under-
taken. In view of multidimensional activity of plant drugs,
we hypothesized that c. roseus leaf would have a complex
mechanism of action; therefore, it was imperative to con-
sider different approaches involved in antidiabetic mecha-
nisms. We specifically assumed that insulin secretagogue
action might be due to improvement in glucose transport
gene (GLUT-2 and GLUT-4) and its effect on transport
proteins and fatty acid metabolism.
Therefore, the present study was designed to inves-
tigate the insulin mimetic impact of c. roseus on the
molecular mechanisms of glucose uptake on STZ-
induced diabetic rats. With these views, we have stud-
ied the effect of c. roseus on glucose transport gene
messenger RNA (mRNA) expression in the liver STZ
model of type 2 DM.
Methods
Preparation of plant extract
Authentic seeds of C. roseus were procured from
National Bureau of Plant Genetic Resources (Accessions
No., IC 49,595), New Delhi, India. Seeds were grown in
the Herbal Garden of Jamia Hamdard, New Delhi, India.
Fresh leaf samples were collected and were completely
dried under shadow for several days. The dried leaves
were grinded into a coarse powder and 100 g powder
was mixed well in petroleum ether and kept for 2 days
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in order to remove all fats, wax and chloroplast etc.
After filtration of the material, it was suspended in
500 mL of 95 % ethanol, and the extraction was per-
formed in soxhlet apparatus for 18 h. Then the solvent
i.e., ethanol was allowed to evaporate using rotary evapor-
ator at a temperature of 40–45 °C. At the end of the
requisite evaporation, we ended up with a highly concen-
trated ethanolic extract which was filtered using a coarse
sieve filter paper. The filtrate was then dried under re-
duced pressure and finally lyophilized. TLC was run for
the ethanolic extract in the solvent system toluene/ethyl
acetate/benzene at 6:3:1 ratio and developed in iodine
chamber. There were spots clearly observed in all three
batches, and Rf values were calculated for standardization
parameters in each batch (Fig. 1). The same spots were
present in all three batches at the same Rf values. Among
few approaches, high performance liquid chromatography
(HPLC) technique is still widely used for the separation
and analysis of secondary metabolites such as those from
C. roseus [28]. Extractive values of ethanol soluble, ash
value, acid-insoluble ash, and moisture contents were
quantified. Phytochemical screening and standardization
of the extract were done before commencement of the in
vivo study.
Animals and housing
Specific pathogen-free 30 male wistar rats, weighing
100–150 g and aged 6 weeks were housed in a colony
cage (six per cage) (Table 1) at an ambient temperature
of 25 °C with 12-h light to 12-h dark cycle. Rats had free
access to standard food and water ad libitum. After over-
night fasting (deprived of food for 16 h and allowed free
access to water), diabetes was induced in rats by intra-
peritoneally injection of Streptozotocin, dose level of
90 mg/kg dissolved in 1 M freshly prepared sodium cit-
rate buffer pH 4.5 to 2-day-old neonatal rats. The con-
trol rats were injected with same amount of citrate
buffer. After 6 weeks of injection for the development of
diabetes, rats were evaluated for fasting glucose level.
The rats with diabetes having glycosuria and hypergly-
cemia (blood glucose range of above 150–200 mg/dl)
were considered as diabetic rats and used for further ex-
periments. The Principles of Laboratory Animal Care
(NIH, 1985) were followed throughout the duration of the
experiment. The entire animal care and surgery were in
accordance with the NIH Guide for the Care and Use of
Laboratory Animals (DHEW Publication No. 85–23). Ap-
proval to do animal experimentation was obtained from
the Institutional Animal Ethics Committee (IAEC) regis-
tered under the Committee for the Purpose of Control
and Supervision of Experimental Animals (173/CPCSEA).
Experimental design
A total of 30 rats were weighted before the experiment,
and they were divided into 5 groups with 6 rats per
group: group 1, normal untreated rats; group 2, diabetic
control rats; group 3 and group 4, diabetic rats treated
with c. roseus 100 mg/kg and 200 mg/kg; and group 5, dia-
betic rats treated with Metformin (100 mg/kg) (Table 2).
After final administration of treatment of 4 weeks, blood
samples were collected under fasting conditions, and the
body weights (BWs) were measured.
Fig. 1 TLC fingerprint of c. roseus in triplicate showing at 366 nm
Table 1 Group of animals
S. No. Group No of Animals Description
1. I 6 Normal Control
2. II 6 Diabetic Control
3. III 6 Treated with 100 mg/kg c. roseus
4. IV 6 Treated with 200 mg/kg croseus
5. V 6 Treated with 100 mg/kg Metformin
Table 2 Effect of c. roseus and Metformin on body weight in
Streptozotocin-induced diabetic rats
Groups Treatment Body weight (g)
Initial (g) Final (g)
I Normal Control Group 147 ± 3.9 155 ± 3.1
II Diabetic Group 152 ± 4.1 110 ± 3.3
III Treated with 100 mg/kg c. roseus 138 ± 4.2 144 ± 3.9
IV Treated with 200 mg/kg c. roseus 142 ± 3.4 149 ± 3.2
V Treated with 100 mg/kg Metformin 137 ± 4.8 148 ± 3.8
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Induction of diabetes
STZ-induced hyperglycemia has been described as a useful
experimental model to study the activity of hypoglycemic
agents [35]. After overnight fasting (deprived of food for
16 h and allowed free access to water), diabetes was in-
duced in rats by intraperitoneal injection of STZ (Sigma,
St. Louis, MO) freshly prepared in 0.1 M sodium citrate
buffer, pH4.5, at a dose of 55 mg/kg body weight [31] in
five groups of rats. The control rats received the same
amount of 0.1 M sodium citrate buffer. After a weeks’ time
for the development of diabetes, the rats with diabetes hav-
ing glycosuria and hyperglycemia (blood glucose range of
above 250–300 mg/dl) were considered as diabetic rats
and used for further experiments.
RNA isolation and reverse transcription
Rats were only mildly anesthetized and killed by cervical
dislocation. Liver was dissected out and rapidly frozen
with tongues cooled to the temperature of liquid nitrogen
and stored at −80 °C until analyzed for glucose transport
gene mRNA content. Total RNA from liver was extracted
with the Qiagen RNEasy Micro kit (GERMANY) includ-
ing an on-column DNAse I digestion step as described in
the manufacturer’s instructions. First-strand complemen-
tary DNA (cDNA) was synthesized at 40 °C by priming
with oligo-dT12–18 (Invitrogen, USA) and using Super
ScriptII reverse transcriptase according to the protocol
provided by the manufacturer (Invitrogen, USA).
Quantitative real time PCR
Real-time polymerase chain reaction (PCR) amplifica-
tions for GLUT-4 (gene ID: 25139) were conducted
using Light-Cycler 480 (Roche, USA) with the SyBr ® I
nucleic acid stain (Invitrogen, USA) according to the
manufacturer’s instructions. The cDNA were assayed by
duplicate prepared from total RNA using Super Script II
(Invitrogen, USA). PCR reactions were performed in a
final volume of 25 μl containing 50 ng of templates com-
plementary DNA (cDNA), 2.5 μl of 10× PCR buffer
(200 mmol/L Tris, pH 8.4, 500 mmol/L KCl, and
2.5 mmol/L MgCl2), 300 μmol/L deoxyribonucleotides
(dNTP), 20 pM of each oligonucleotide, 1:1000 SyBr
Green I® nucleic acid stain, 100 μg/ml BSA, 1 % glycerol,
0.5 U Taq DNA Polymerase (Invitrogen, USA) final vol-
ume maintained with ddH2O. Sets of PCR primers of
GLUT-2 sense 5′-CGA CTC GAT CCG TTG GCC
TGT CAG CTT GC-3′ and antisense 5′- TGT GTG
GAA TTG TCC TCT TAA TCC AGG TCC TG -3′
(Genbank Accession No. NM-012879.2); GLUT-4 sense
5′- TAG AAT TCC CCG GAC CCT ATA CCC TAT
TCA TTT-3′ and antisense 5′- TAG GAT CCG CTG
TAG AGG AAA GGA GGG AGT CTG -3′ (Genebank
Accession No. D28561); and for β-actin sense 5′-TCA
CCC ACA CTG TGC CCC ATC TAC GA-3′ and anti-
sense 5′ CAG CGG AAC CGC TCA TTG CCA ATG
G-3′ (Genebank Accession No. NM031144.2) were de-
signed with reference to the National Centre for Bio-
technology Information (NCBI) database of conserved
coding regions. Thermal cycling conditions were per-
formed 95 °C for a 2.5 min initial denaturation step
followed by 40 PCR cycles (94 °C for 20 s, 58 °C for
30 s, and 72 °C for 50 s). Fluorescence was detected at
the end of the 58 °C segment. Polymerase chain reaction
products of β-actin primer gene were used as an internal
standard. Amplifications were performed in duplicate for
the entire samples. Real-time PCR analysis and subse-
quent calculations were performed on Light-Cycler 480
software (version LCS480 1.2.0.169; Roche). The relative
starting quantity of each transcript was determined
using the comparative CT method for relative quantifica-
tion [36].
Statistical analysis
The results are expressed as mean ± SD. Statistical
evaluation was carried out using ANOVA followed by
Dunnett’s test between the groups. Differences were
considered significant at p < 0.05 and highly significant
at p < 0.01.
Table 3 Effect of ethanolic extract of c. roseus on some biochemical parameter on rats
Dose mg/kg GLU mg/dl CHOL mg/dl CRE Umol/L ALP IU/L ALT IU/L AST IU/L GST IU/L BUN mg/dl
Normal Control Group 98.9 ± 2.28 59.12 ± 5.08 107.24 ± 4.08 102.4 ± 3.81 56.82 ± 5.04 87.28 ± 5.83 0.59 ± 0.05 38.40 ± 2.36
Diabetic Control
Group
256.32 ± 8.64 117.34 ± 2.20 196.74 ± 2.84 286.21 ± 5.34 134.20 ± 7.41 37.43 ± 4.59 0.45 ± 0.06 116.2 ± 1.24
Treated with
100 mg/kg C. roseus
189.42 ± 11.2* 92.49 ± 7.17* 168.26 ± 6.23* 185.36 ± 4.32* 98.64 ± 8.80* 116.16 ± 4.51* 0.44 ± 0.07 86.26 ± 2.49*
Treated with
200 mg/kg C. roseus
153.34 ± 6.72** 85.43 ± 6.61** 132.41 ± 6.31** 150.42 ± 4.78** 81.38 ± 4.86** 125.29 ± 5.09 0.44 ± 0.07 65.41 ± 5.23**
Treated with
100 mg/kg Metformin
135.56 ± 9.72** 68.04 ± 5.80** 127.74 ± 3.16** 126.46 ± 3.68** 76.44 ± 4.72** 129.52 ± 3.96** 0.44 ± 0.07 45.72 ± 4.84**
Results are mean ± SD, n05
GLU glucose, CHOL cholesterol, CRE creatinine, ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate transaminase, GST Glutathione S-transferase, BUN
blood urea nitrogen
Values are expressed as mean ± SD for six animals in each group. *Level of significance p < 0.05, **Level of significance p < 0.01
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Results
In Diabetic rats treated with ethanolic extract of c. roseus
leaf and metformin, there were no significant differences of
baseline body weight of the rats. The rats treated with c.
roseus 100 mg/kg, 200 mg/kg and metformin 100 mg/kg
showed no significant increase in body weight as compared
with diabetic groups after 4 weeks of study. Blood glucose
level of every 2 day (0.1–0.2 ml blood collected from tail)
interval showed significance with treatment of c. roseus to
diabetic animal group in comparison to metformin-treated
group for 20 days (Table 3). C. roseus (100 mg/kg BW)
lowered the glucose level than metformin-treated group
(100 mg/kg BW) (Table 4). C. roseus 200 mg/kg dose was
found to be more effective in reducing fasting blood
glucose levels Fig. 2.
RNA concentrations were measured from liver samples.
It was therefore necessary to confirm that the control gene
for quantitative real time PCR was not over-represented.
We measured transcription of the control β-actin in
cDNA prepared from these samples, quantified it using
the standard curve method. As shown in Fig. 2, the ampli-
fication efficiency (E) for genes was determined by linear
regression analysis of the fluorescent data from the
exponential phase of PCR [37]. Quantitative reverse tran-
scription RT-PCR results showed increase in liver GLUT-
2 mRNA and GLUT-4 mRNA concentrations after
4 weeks treatment of c. roses as compared with corre-
sponding vehicle-treated diabetic rats.
Because there was an increase in plasma insulin
levels in c. roseus treated diabetic rats and because of
the physiologic importance of insulin-dependent glu-
cose transport gene (GLUT-2 and GLUT-4) transloca-
tion to the cell membrane, attempts have been made
to see the effect of c. roseus treatment on liver tissue
GLUT-2 and GLUT-4 levels. In the liver and muscle
membrane fractions of diabetic rats, the translocation
of GLUT-2 and GLUT-4 was very much reduced
when compared with the band density of healthy con-
trols. This is quite rational because the deficiency of insu-
lin in the diabetic state would decrease the translocation
of GLUT-2 and GLUT-4 from the vesicles to cell mem-
branes. Treatment with c. roseus resulted in the reversal of
membrane GLUT-2 and GLUT-4 levels. The glucose
transport gene (GLUT-2 and GLUT-4) levels of normal
control, diabetic, and c. roseus -treated diabetic rats are
shown in Fig. 3.
Table 4 Effect of ethanolic extract of c. roseus on blood sugar at different time intervals in steptozotocin-induced diabetic rats




8th day 11th day 14th day 17th day 20th day 23th day 26th day 28th day
Normal Control Group 113 ± 3.5 107 ± 3.4 109 ± 3.9 115 ± 4.2 112 ± 4.3 108 ± 3.3 109 ± 2.9 105 ± 3.3 110 ± 2.9
Diabetic Group 112 ± 4.4 248 ± 3.8 281 ± 3.1 299 ± 3.9 314 ± 3.1 329 ± 3.6 343 ± 3.5 373 ± 3.1 398 ± 3.4
Treated with 100 mg/kg c. roseus 118 ± 4.8 254 ± 3.1 242 ± 4.3 235 ± 4.7 224 ± 4.0 212 ± 3.7 195 ± 4.3 180 ± 4.1 138 ± 4.8
Treated with 200 mg/kg c. roseus 114 ± 3.9 269 ± 3.9 232 ± 4.1 223 ± 3.6 218 ± 4.4 205 ± 4.7 190 ± 3.3 169 ± 4.5 123 ± 4.1
Treated with 100 mg/kg Metformin 117 ± 4.1 247 ± 3.2 243 ± 3.6 238 ± 3.1 225 ± 3.6 214 ± 3.6 201 ± 3.9 188 ± 3.6 141 ± 3.5
Fig. 2 Effect of c. roseus on GLUT-2 & GLUT-4 mRNA level with deferent concentration 100 mg/kg on GLUT-2, 100 mg/kg on GLUT-4, 200 mg/kg
on GLUT-2 and 200 mg/kg on GLUT-4
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Discussion
Diabetes mellitus is an endocrine and metabolic disorder
indicated by chronic hyperglycemia that produces bio-
chemical changes and tissue destruction. Several obsta-
cles of biochemical changes and tissue destruction like
atherosclerosis, neuropathy, nephropathy, etc. have
chronically elevated glucose levels due to glycosylation
and metabolic disorder. Diabetic stress and other bio-
logical changes in tissue have been reduced by antioxi-
dants [38]. STZ induced hyperglycemia in rodents is
considered to be a good preliminary screening model
[39] and is widely used. STZ is a potent methylating
agent for DNA and acts as nitric oxide donor in pancre-
atic cells. Literature for synthetic drugs for diabetes mel-
litus tells that most of these drugs have many side
effects. So, scientists are in search of safe, natural anti-
diabetic agents that can cure the diabetes without caus-
ing harm, and the World Health Organization has also
recommended the development of herbal medicine in
this concern [40].
In the present study, a significant blood glucose reduc-
tion was observed in healthy rats after the intraperitoneal
administration of ethanolic extract of c. roseus leaf
100 mg/kg and 200 mg/kg and metformin 100 mg/kg in a
Fig. 3 Simultaneous amplification plots and standard curves of GLUT-2 & 4 mRNA by fluorescence real-time PCR. a. Plot of threshold cycle number
(Ct) vs. serial dilutions (log10) of standard DNA from 101 to 108 copies/reaction tube were prepared. Reaction number increases during PCR as the
amplicon copy number increases until the reaction reaches a plateau. Ct was plotted against each copy number. Ct represents the PCR cycle at
which reporter signal can first be detected. b. Standard curve showing efficiency of amplification during PCR
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preclinical model of STZ-induced type 2 diabetes for
period of 4 weeks. The body weight of diabetic rats was
found to be less during the course of the development,
which may be because of accelerated lipolysis, whereas
weight gain was significantly observed in rats treated for
4 weeks with c. roseus treated and metformin. Significant
changes are observed after c. roseus treatment in the dis-
tribution of insulin, glucagon, and glucose transport gene
(GLUT-2 and GLUT-4). The level of glucose transport
gene increases markedly in the c. roseus treated sample is
much greater in the untreated rats when compared with
control animals. The glucose transport gene expression is
down-regulated when there is relative insulin deficiency,
such as in STZ-induced diabetes [41].
After treatment with c. roseus, the contents of glucose
transport gene mRNA were restored to near normal
values. The decrease in glucose transport gene levels is
essentially one of the main reasons of hyperglycemia in
the diabetic state, which is due to decreased uptake of
glucose. Restoration of glucose transport gene levels
would, therefore, enhance the uptake of glucose in liver
and thus help to combat hyperglycemic conditions. Glu-
cose unresponsiveness associated with GLUT gene impair-
ment is typically demonstrated in type 2 diabetes [42].
Conclusion
In conclusion, the c. roseus plant ethanol extract was
found to exhibit a significant anti hyperglycemic activity
in STZ-induced diabetic rats. The results from blood
glucose, serum biochemical estimation and glucose
transport gene (GLUT-2 and GLUT-4) mRNA indicated
that the c. roseus has renewing and healing ingredients
as it could reverse most blood and tissue changes caused
by STZ-induced diabetes in rats.
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